Indian brothers lose appeal over pharma award
Daiichi Sankyo’s acquired a controlling stake in Ranbaxy Laboratories from the Singhs and other shareholders (Credit: Shutterstock/Julia Sudnitskaya)
The Singapore Court of Appeal has upheld a US$530 million ICC award that found Indian brothers Malvinder and Shivinder Mohan Singh liable for fraud over the sale of a pharmaceutical business.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Subscribe now